Editorial: Tenofovir disoproxil fumarate more than an antiviral drug—Another piece of the puzzle. Authors' reply-Reference-Cited by-同舟云学术

Editorial: Tenofovir disoproxil fumarate more than an antiviral drug—Another piece of the puzzle. Authors' reply

Published:2023-12-28 Issue:2 Volume:59 Page:289-290
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Cheng Pin‐Nan¹,Liu Chun‐Jen²^ORCID

Affiliation:

1. Department of Internal Medicine National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

2. Department of Internal Medicine National Taiwan University Hospital, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei Taiwan

Abstract

LINKED CONTENTThis article is linked to Cheng et al papers. To view these articles, visit https://doi.org/10.1111/apt.17765 and https://doi.org/10.1111/apt.17793

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17807

Reference9 articles.

1. Editorial: tenofovir disoproxil fumarate more than an antiviral drug – another piece of the puzzle;Mauss S;Aliment Pharmacol Ther,2024

2. Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both Hepatitis B and C strains independently

3. Hepatitis B virus infection and fatty liver in the general population

4. Comparison of cardiovascular outcomes and all-cause mortality in patients with chronic hepatitis B and C: A 13-year nationwide population-based study in Asia

5. Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers